Bin Xu
机构:Nanjing University of Chinese Medicine, Guilin Medical University, Jilin University, Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Stavros Niarchos Foundation, New York Psychoanalytic Society and Institute, Wuhan University, Shanghai Ninth People's Hospital, Jiangxi Provincial Cancer Hospital, First Hospital of Jilin University, Zhongshan Hospital, Renmin Hospital of Wuhan University, Guangxi Center for Disease Prevention and Control, China Academy Of Machinery Science & Technology (China), Second Affiliated Hospital of Zhejiang University, Columbia University, South China University of Technology · ORCID:0000-0001-5511-8055
发表论文 516 篇 · 总被引 9057 次 · h-index 45
代表论文
- Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation (2024 · Drug Resistance Updates · 被引 18)
- Fungi, immunosenescence and cancer (2025 · Seminars in Cancer Biology · 被引 17)
- CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance (2025 · Advanced Science · 被引 13)
- Concentrations, sources and health risks of per- and polyfluoroalkyl substances in ambient PM1 in the Pearl River Delta region, China (2025 · Environment International · 被引 13)
- Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity and Inform Therapeutic Strategies (2025 · Biomedicines · 被引 8)
- Exosome-delivered NR2F1-AS1 and NR2F1 drive phenotypic transition from dormancy to proliferation in treatment-resistant prostate cancer via stabilizing hormonal receptors (2024 · Journal of Nanobiotechnology · 被引 7)